The course of action:
Pharmaceutical company Pfizer wanted to develop a medicine for angina, chest pains and high blood pressure – a great intention. Pfizer invested in and carried out clinical trials for 6 years under the leadership of Ian Osterloh. As far as is known the research was carried out properly and there were no mishaps. Except…
The result:
After 6 years it became clear that the medicine did not have the desired effects. However, many patients reported erections and improved potency as side effects.
The lesson:
Pfizer radically changed strategy and tested the new medicine against erection disorders.
Further:
Today, every second, someone somewhere is taking a Viagra pill.
Published by:
Redactie IVBM
OTHER BRILLIANT FAILURES
The Museum of Failed Products
Robert McMath - a marketing professional - intended to accumulate a reference library of consumer products. The course of action was Starting in the 1960s he started to purchase and preserve a sample of every [...]
The Norwegian Linie Aquavit
The course of action: The concept of Linie Aquavit happened by accident in the 1800s. Aquavit (pronounced 'AH-keh'veet' and sometimes spelled "akvavit") is a potato-based liquor, flavored with caraway. Jørgen Lysholm owned a Aquavit distillery in [...]
Inspectie Volksgezondheid Aruba en LHM Diagnostiek winnen de Briljante Mislukkingen Awards Zorg 2023
Op 13 september jl. werden voor de negende keer de Briljante Mislukkingen Awards uitgereikt tijdens een feestelijk evenement bij Zilveren Kruis Achmea in Leiden.